throbber
Section 14
`
`Avicel® RC/CL, Microcrystalline Cellulose
`and Carboxymethylcellulose Sodium, NF, BP
`By Sheila M. Dell, Ph.D. and John A. Colliopoulos, M.S.
`
`Table of Contents
`
`Avicel RC/CL, Microcrystalline Cellulose and Carboxymethylcellulose Sodium, NF, BP..............1
`Table of Contents.......................................................................................................................1
`Introduction ....................................................................................................................................3
`Disperse Systems ......................................................................................................................3
`Guidelines for Suspension Formulation.....................................................................................3
`Particle Size ...........................................................................................................................4
`Wetting ...................................................................................................................................4
`Viscosity .................................................................................................................................4
`Flocculation and Deflocculation ............................................................................................5
`Characteristics of Commonly Used Suspending Agents ..........................................................6
`Avicel RC and CL, Microcrystalline Cellulose
`and Carboxymethylcellulose Sodium, NF, BP....................................................................6
`Carrageenan, NF....................................................................................................................7
`Algins and Alginate ................................................................................................................7
`Other Commonly Used Suspending Agents .........................................................................8
`Other Suspension Excipients.................................................................................................9
`Avicel RC and Microcrystalline Cellulose, NF..............................................................................11
`Introduction ..............................................................................................................................11
`Structure and Properties..........................................................................................................11
`Chemical and Physical Specifications.................................................................................12
`Microbiological Specifications .............................................................................................13
`Effect of pH and Temperature on the Viscosity of Colloidal Avicel .........................................13
`Effect of Other Hydrocolloids on Viscosity ..............................................................................13
`Advantages of Formulating Disperse Systems with Colloidal Avicel ......................................14
`Preparation of Colloidal Avicel.....................................................................................................15
`Dry Mix Dispersion...................................................................................................................15
`Liquid Mix Dispersion ..............................................................................................................15
`Rheology of Avicel Dispersions ...................................................................................................15
`Viscoelastic Properties.............................................................................................................15
`Pharmaceutical Applications .......................................................................................................21
`Example of Use of Colloidal Avicel as a Suspending Agent ...................................................21
`Example of an Analgesic Oral Suspension Using Colloidal Avicel RC-591 ............................21
`Example of an Antacid Suspension Using Colloidal Avicel RC-591 .......................................22
`
`1
`
`Exhibit 1146
`IPR2017-00807
`ARGENTUM
`
`000001
`
`

`

`Example of Use of Colloidal Avicel® as an Oil/Water Emulsifier..............................................22
`Example of Use of Colloidal Avicel as a Thickener, Emulsion Stabilizer
`and Opacifier for Pharmaceutical Creams and Gels ...........................................................23
`Example of Use of Colloidal Avicel as an Oil/Water Emulsifier
`for Cosmetic Lotions............................................................................................................23
`Example of Use of Colloidal Avicel as a Suspending Agent
`for Reconstitutable Suspensions.........................................................................................24
`Suspension Powder for Reconstitution ...............................................................................24
`Example of a Drug (Active) Powder Formualtion for Reconstitution...................................24
`Equipment and Suppliers.............................................................................................................25
`Mixers.......................................................................................................................................25
`Mills .........................................................................................................................................25
`Deaerator-Defoamer.................................................................................................................26
`Micronizer-Pulverizer................................................................................................................26
`Viscometers..............................................................................................................................26
`Rheometers..............................................................................................................................26
`Special Equipment ...................................................................................................................26
`Particle Size Analyzer...............................................................................................................26
`References ...................................................................................................................................27
`Acknowledgement .......................................................................................................................27
`
`2
`
`000002
`
`

`

`Introduction
`
`Disperse Systems
`
`The science of suspensions and dispersions
`is fundamental in the field of food, drugs and
`cosmetics where the drug or actives are neither
`soluble nor precipitated. Disperse systems are
`classified broadly as systems in which one
`substance, the dispersed phase, is distributed
`throughout another substance, the continuous
`phase. Examples of disperse systems are
`suspensions, emulsions, creams, ointments,
`aerosols, pastes, etc. These dosage forms
`can be administered by oral, ophthalmic,
`intranasal, dermatological or by parental
`routes of administration.
`
`One of the most important challenges of a
`disperse system is to have the dispersed
`phase remain dispersed in the dispersion
`medium. Thus, the control of sedimentation
`is of primary importance in maintaining the
`integrity of a disperse system.The most
`practical method of controlling sedimentation
`is by the use of viscosity building agents.
`Various substances, such as sugars and
`polyols, have been used over the years to
`build viscosity in aqueous drug systems.
`However, they needed to be used in large
`amounts to achieve the required viscosity
`and these solutions are usually Newtonian
`in nature. Polymers, on the other hand, are
`needed in small amounts to meet the viscosity
`requirements and have the added advantage
`of being non-Newtonian in nature, i.e., they
`have a yield point or are thixotropic. These
`properties are advantageous in overcoming
`sedimentation and are easier to process. Thus,
`polymers are used in suspensions, emulsions
`and other dispersions mainly to control or
`minimize sedimentation. Various substances
`such as natural, synthetic and semi-synthetic
`polymers, have been used over the years to
`build viscosity in aqueous drug systems.
`
`The objective of this chapter is to highlight the
`features of colloidal Avicel®, a polymer that is
`a combination of microcrystalline cellulose and
`
`sodium carboxymethylcellulose as a suspending
`agent/thickener, etc. in oral suspensions, creams
`and lotions. The bulk of the information present-
`ed is from reviews of FMC literature, brochures
`technical reports, Kennon and Storz (1), Nash (2),
`Boylan (3), Macek (4) and Haines and Martin (5).
`
`Guidelines for Formulation
`of a Suspension
`
`Oral aqueous suspensions constitute the
`largest portion of suspensions marketed in the
`pharmaceutical industry. Drugs are dispensed
`as suspensions for various reasons, the primary
`one being poor aqueous solubility. Suspensions
`also improve the taste since less of the drug is
`in solution. In addition, greater chemical stability
`is achieved since the drug is not in solution and,
`in some cases, bioavailability is enhanced. This
`is of particular importance to children and
`geriatric patients. Suspensions also offer
`advantages for those patients who have
`difficulty swallowing tablets or capsules.
`
`A suspension can be defined as a two-phase
`system consisting of a finely divided solid
`dispersed in a solid, liquid or gas. Oral
`suspensions usually have the active drug,
`which is insoluble or poorly water soluble,
`dispersed in water (liquid), which is the
`continuous phase.
`
`The main objective in suspension formulation
`is to ensure that the dispersed particles do not
`settle on standing, or if the particles do settle,
`the particles should be easily dispersed on
`shaking and should produce a uniform dose on
`administration. The suspension should also be
`pleasant tasting, and be stable physically and
`chemically. Since the specific properties of
`various suspended drugs differ, no single
`procedure will always produce a successful
`suspension product. However, certain principles
`are affirmed to be fundamental in all successful
`formulations.
`
`3
`
`000003
`
`

`

`They are:
`1. Particle size of the suspended drug
`2. Wetting/surfactants
`3. Viscosity
`4. Flocculation/deflocculation
`
`Particle Size
`
`A major goal of a suspension formulation is
`to slow or prevent sedimentation of the drug
`particle to avoid a non-uniform distribution of
`the drug. The particle size of the drug plays a
`significant part in determining formulation
`elegance, rate of settling, absence of caking,
`rate of drug release and final stability of the
`product.
`
`Particle size of the suspended drug is a
`critical parameter in a suspension formulation.
`According to Stokes’ Law, the rate of settling
`of the insoluble drug is directly proportional
`to the square of the particle diameter.
`
`V ⫽ d2
`
`共␳1 ⫺ ␳2兲g
`18␩
`
`where V = sedimentation rate of a particle
`d = mean particle diameter
`␳1 = particle density
`␳2 = density of the dispersion medium
`g = acceleration due to gravity
`␩ = viscosity of the dispersion medium
`
`Therefore, smaller particles will settle more
`slowly than larger particles. The majority of
`pharmaceutical suspensions have drug particles
`in the range of 1-50 microns in diameter. If
`particles are less than about 3 microns and their
`density does not differ by more than 20% from
`that of the dispersion vehicle, the particles will
`remain suspended due to Brownian motion.
`Therefore, reduction of particle size has a
`beneficial effect upon the physical stability of
`the suspension. In practice, however, there is
`a limit to particle size reduction because, after
`reaching a certain particle size, further reduction
`can be expensive due to the time and equipment
`involved. Moreover, movement of small particles
`due to Brownian motion often produces particle
`
`aggregation, followed by settling of the
`aggregates and frequently caking. Redispersion
`of the drug after caking is often impossible.
`
`Wetting
`
`Since most drugs in a suspension are
`hydrophobic, they float on the surface of
`the dispersion medium due to poor wetting.
`A wetting agent helps disperse the poorly
`soluble drug in the dispersion medium. Wetting
`of the solid phase by the suspended liquid is
`necessary to produce a good suspension. Low
`concentrations of surfactants are commonly
`used as wetting agents to aid dispersion of the
`particles in the suspension vehicle. However,
`excess amounts of surfactants may impart
`foaming or an unpleasant taste.
`
`Viscosity
`
`Stokes’ Law describes the inverse relationship
`between viscosity of the dispersion medium
`and rate of particle settling. An increase in
`viscosity produces a slower sedimentation
`rate and increases physical stability. The most
`common method of increasing viscosity is by
`adding a suspending agent. Suspending agents
`with high viscosity do not always prevent
`sedimentation. Meyer and Cohen in 1959 (6)
`suggested that yield value is an important
`mechanism to keep a particle suspended.
`The yield value for a suspension must balance
`or exceed the force of gravity on the settling
`particles. This mechanism is gaining recognition
`and was reviewed by Hem and White. (7)
`The yield value of a dispersion medium can
`be determined experimentally by using a rota-
`tional viscometer and plotting shear stress
`(dyne/cm2 ) as a function of shear rate (sec-1).
`The curve as shown in the Figure 1 does not
`pass through the origin, but intersects the axis
`of shear stress as in curves A and B. The inter-
`section at C or D is the yield value. The slope
`of the curve is the apparent viscosity, which
`varies with shear rate, and therefore, the entire
`curve is required to describe the viscosity of
`these systems. Additional information on the
`
`4
`
`000004
`
`

`

`One such process is flocculation. Flocculation
`is a process in which particles are allowed to
`come together and form loose agglomerates.
`The chief advantage of a flocculated suspension
`is in its redispersibility. The goal of controlled
`flocculation is to maintain reasonably sized
`aggregates or flocs. In this way, redispersibility
`and sedimentation rate are kept in balance.
`
`Flocculation can be achieved by various
`means. One of the methods is based on electric
`charge. Charged particles of the same charge
`will repel each other and thus resist forming
`flocs. Reduction of particle repulsion permits
`the particles to get close enough to allow the
`attractive forces to dominate.
`
`The use of polymers is another method to
`achieve flocculation. Polymers containing
`chemical groups that interact with the
`suspended particles can be added to the
`continuous phase. Polymer segments can
`then attach to individual particles to form a
`polymer-particle complex. As the polymer
`connects across two or more particles a floc
`is formed. Other ingredients such as protective
`colloids (e.g., carboxymethylcellulose), wetting
`agents such as polysorbates, and electrolytes
`such as sodium chloride can also act as
`flocculating agents.
`
`The final suspension product should be
`evaluated for its stability in the final package
`after manufacture, at various temperature
`conditions for a given period of time to ensure
`physical and chemical stability. Several physical
`tests are employed to determine the stability
`of a suspension. The list below shows the
`various tests a formulator would conduct to
`determine the stability of a suspension, Ofner,
`Schnaare and Schwartz (8).
`
`rheological properties of suspending agents and
`suspensions will be covered in this chapter.
`
`Figure 1: Yield Value
`
`Reducing the difference in density between the
`particles and the dispersion medium can also
`lower the rate of sedimentation. However, water
`is usually the dispersion medium, and since
`added ingredients do not change its density
`to a great extent, i.e., this has not been a partic-
`ularly successful method. Therefore, particle
`size and viscosity have been the properties
`that most formulators focus on to obtaining
`an optimum suspension formulation.
`
`Flocculation and Deflocculation
`
`The basic concern in developing a suitable
`suspension is to control adequately the rate of
`settling and ease of redispersion, as well as to
`prevent caking of the particles as a dense
`mass at the bottom of the container. Particle
`size reduction produces slower, more uniform
`rates of settling. Frequently, caking cannot be
`prevented by adding a suspending agent or
`reducing the particle size; in fact, these
`measures sometimes aggravate the problem
`of caking. The best approach to this problem
`is to achieve a controlled flocculation of the
`particles, where they appear as floccules or
`like tufts of wool with a loose fibrous structure.
`When such a system settles, two distinct layers
`form, a clear particle-free supernatant and a
`sediment. The particles are held together by
`weak van der Waals forces. Maintaining a drug
`in suspension with little or no separation results
`in a more elegant and permanent suspension.
`
`5
`
`000005
`
`

`

`Avicel® RC and CL Microcrystalline Cellulose
`and Carboxymethylcellulose Sodium, NF;
`Dispersible Cellulose, BP
`
`FMC BioPolymer
`1735 Market Street
`Philadelphia, PA 19103
`
`Derivation
`Colloidal Avicel is a modified microcrystalline
`cellulose product. It has a composition, on a
`dry basis, of 82-89% microcrystalline cellulose
`and 11-18% sodium carboxymethylcellulose,
`medium viscosity.
`
`Water Dispersibility
`Colloidal Avicel is a water-dispersible anionic
`hydrocolloid.
`
`pH Stability
`Colloidal Avicel is stable over a pH range of
`3.5-11.
`
`Rheology
`1. Colloidal Avicel systems form thixotropic
`gels which have a finite yield value at low
`concentrations.
`2. These gels are shear thinning and upon
`resting the yield value increases to re-estab-
`lish the equilibrium value. Colloidal Avicel is
`a stable product. Its viscosity is unaffected
`by temperature.
`
`Incompatibilities
`Colloidal Avicel being anionic by nature
`flocculates when small amounts of electrolyte,
`cationic polymers or surfactants are added.
`
`Advantages
`The advantages and uses of Avicel RC and CL
`will be discussed in detail in the following
`sections of this chapter.
`
`Summary of Physical Tests for Suspension
`Stability; The Stability of Actives is Assumed
`
`1. Appearance
`2. Sedimentation rate
`3. Sedimentation volume
`4. Redispersibility
`5. Zeta potential measurement
`6. Dissolution
`7. Rheological measurements
`8. Stress tests-Vibration-Transportation
`9. pH
`10. Specific gravity
`11. Odor
`12. Taste
`13. Color-Light
`14. Microbiological examination
`15. Freeze-thaw cycles
`16. Compatibility with container
`17. Compatibility with cap liner
`18. Torque
`19. Microscopic-Photomicrographs
`20. Crystal size
`21. Uniform drug distribution
`22. Toxicity
`23. Use tests
`
`Characteristics of Commonly Used
`Suspending Agents
`
`One of the most important factors in
`formulating a suspension is selection of the
`proper suspending agent. It is the suspending
`agent that is used primarily to control or mini-
`mize sedimentation. The formulator must
`select the suspending agent best suited to
`support the drug in either a flocculated or
`deflocculated state.
`
`The following listing of suspending agents and
`protective hydrocolloids most commonly used
`in the pharmaceutical industry provides pertinent
`functional, rheological and incompatibility
`characteristics, and is designed to give the
`formulator a quick overview. The many grades
`available for some particular hydrocolloids are
`not dealt with in this overview, and the formula-
`tor is referred to company literature, Idson and
`Scheer (9).
`
`6
`
`000006
`
`

`

`Carrageenan, NF
`
`FMC BioPolymer
`1735 Market Street
`Philadelphia, PA 19103
`
`Algins and Alginate
`
`FMC BioPolymer
`1735 Market Street
`Philadelphia, PA 19103
`
`Derivation
`Carrageenan is an anaerobic polysaccharide
`derived from seaweed. Different types of
`Carrageenan have been identified such as
`kappa, iota and lambda Carrageenan. (See
`Chapter on carrageenan in Problem Solver).
`
`Water Dispersibility
`All forms of carrageenan are soluble in hot water,
`but only the sodium salts of iota carrageenan
`and lambda carrageenan are soluble in cold
`water. In the presence of certain ions such as
`calcium or potassium, gels of great strength
`are formed with definite melting temperatures.
`
`pH Stability
`Carrageenans are stable over a pH range of
`4-10. They are least stable under either strongly
`acidic or alkaline solutions. Carrageenan
`solutions generally have a pH of 6-10.
`
`Rheology
`1. Carrageenans, especially the iota and kappa
`types, form thixotropic gels with a yield point
`at low concentrations.
`2. A reversible loss in viscosity is seen at higher
`temperatures.
`
`Incompatibilities
`Carrageenans are anionic in nature and
`therefore are incompatible with cationics.
`Mono- and divalent ions such as potassium
`and calcium will crosslink the polymer to
`form gels. They hydrolyze and degrade in
`the presence of strong acids.
`
`Advantages
`1. Carrageenans are thickeners, film formers
`and suspending agents.
`
`Derivation
`Alginates are purified hydrocolloids obtained
`from brown seaweed (Kelp extract). (See chapter
`on Algins/Alginate in Problem Solver).
`
`Water Dispersibility
`Alginate is readily water dispersible and can be
`either pre-blended with other drug excipients like
`sucrose or wetted with glycols prior to
`water addition. High speed stirring is indicated.
`
`pH Stability
`Alginate is stable over a pH range of 4-10.
`
`Rheology
`1. Alginate systems exhibit pseudoplastic
`behavior.
`2. Long term accelerated temperature
`conditions produce some viscosity losses
`(depolymerization).
`
`Incompatibilities
`Alginate is anionic in nature and therefore
`are incompatible with cationics. Calcium salts
`precipitate algins. Polyvalent ions will crosslink
`the polymer to form gels.
`
`Algins are incompatible with heavy metal ions.
`They are sensitive to strong acids.
`
`Advantages
`1. Alginates are colloidal electrolytes.
`2. Alginates are stabilizers, film formers
`and reasonable suspending agents.
`
`Note: The formulator must strictly monitor rheological
`properties of alginate suspensions.
`
`7
`
`000007
`
`

`

`Other Commonly Used Suspending Agents
`
`The pH stability, rheology, incompatibilities and uses of other common suspending agents
`are listed in alphabetical order.
`
`Suspending Agent
`
`pH Stability (Range)
`
`Rheology
`
`Carbomer, NF
`
`5.0 - 11
`
`Systems exhibit plastic
`flow
`
`Methylcellulose, USP
`
`3.0 - 11
`
`Dispersions are
`pseudoplastic
`
`Sodium Carboxy-
`methylcellulose, NF
`(Cellulose gum)
`(NaCMC)
`
`4.0 - 10.0
`
`Acacia, NF
`(Gum Arabic)
`
`Viscosity is
`affected by pH
`
`CMC systems exhibit
`pseudoplastic behavior.
`Viscosity of CMC systems
`is dependent upon
`temperature.
`
`Newtonian flow exhibited
`at concentrations below
`40%. High concentrations
`are pseudoplastic.
`
`Guar Gum, NF
`
`4 - 10
`Maximum viscosity
`is obtained at pH 6
`
`Pseudoplastic behavior
`with no yield point.
`
`Incompatibilities
`Sensitive to soluble salts;
`mono-, di- and polyvalent
`and to cationic polymers.
`
`High levels of electrolytes
`and surfacants affect MC
`dispersions.
`
`Incompatible with di- and
`trivalent salts.
`
`Acacia is anionic.
`It flocculates with small
`amounts of electrolytes,
`cationic polymers and
`surfacants.
`
`May degrade irreversibly
`with time at elevated
`temperatures.
`
`Uses
`
`Good suspending agent
`at a pH value of 5.0
`
`Effective stabilizer and
`protective colloid. Usually
`used in conjunction with
`other suspending agents,
`not as a primary
`suspending agent.
`
`Effective stabilizer
`and protective colloid
`especially for Avicel®
`RC-591 MCC.
`
`—
`
`—
`
`Xanthan Gum, NF
`
`3.0 - 11.0
`
`Dispersions are extremely
`pseudoplastic with
`significant yield value.
`
`Incompatible with cationic
`dyes and polyvalent ions
`at high pH.
`
`Effective suspending
`agent especially when
`used in conjunction
`with Avicel CL-611 MCC.
`
`Should the formulator decide to use a natural gum either as a sole or adjunct suspending agent, strict
`attention must be given to the natural source derivation and rigid specifications regarding lot-to-lot
`uniformity must be implemented.
`
`8
`
`000008
`
`

`

`Other Suspension Excipients
`
`• Functions
`• Use levels
`• Problems
`
`The function, percent use level and problems that could surface relative to commonly used suspension
`excipients are listed in alphabetical order.
`
`Percent levels used are approximate and represent general use levels.
`
`Excipient
`
`Purpose
`
`% W/V Range Used
`
`Problem
`
`Could solubilize small percentage of drug.
`Incompatibility with suspending agent.
`
`pH of the system should be below 4.5
`for the preservative to be effective.
`Solubility, precipitation not uncommon.
`
`Incompatibility with drug or suspending
`agent.
`
`Excessive levels may cause staining
`of teeth, skin, or clothing.
`Quaternary ammonium compounds
`interact with FD&C Blue #1 and FD&C
`Yellow #10
`
`— R
`
`eactions with drug and/or other flavors.
`Excessive levels impart bitterness,
`burning sensation.
`
`Could impart hot acrid taste at high
`levels.
`
`0.1-0.2
`
`0.01-0.1
`
`Can impart an objectionable taste and a
`feeling of numbness at high levels.
`
`Poor water solubility.
`
`5-10
`
`Unpleasant taste.
`
`Sodium Benzoate
`
`Preservative.
`
`0.05-0.25
`
`See Benzoic Acid
`
`9
`
`Alcohol 95%, USP
`
`Solvent for preservatives,
`flavors, or other insolubles.
`
`Benzoic Acid
`
`Preservative.
`
`3-10
`
`0.05-0.25
`
`Buffer Acids
`
`pH adjustment buffer system.
`
`Depends on pH of system
`
`Colorants
`
`Provides color-system.
`
`q.s.
`
`Disodium Edetate
`(Na2 EDTA)
`
`Sequesterant.
`
`0.001-0.005
`
`q.s.
`
`5-15
`
`Flavors
`
`Taste improvement.
`
`Glycerin
`
`Solvent for preservatives.
`Bodying agent.
`Drug dispersing vehicle.
`Used with Sorbitol in
`combination to produce
`cap lock resistant blends.
`
`Methyl Paraben
`
`Propyl Paraben
`
`Preservative.
`Preservative.
`
`Propylene Glycol
`
`Solvent for preservative
`or flavors.
`Drug dispersing vehicle.
`
`000009
`
`

`

`Other Suspension Excipients Continued.....
`
`Excipient
`
`Sodium Chloride
`
`Sorbitol
`Solution, 70%
`
`Purpose
`Modification of bitterness.
`Taste modifier.
`Improves flavor.
`Imparts sweet cool taste.
`Bodying agent.
`Helps retard cap locking
`tendency.
`
`Sucrose
`
`Natural sweetener.
`
`Pluronic Polyol – F68
`(HLB = 5.8)
`
`Wetting agent.
`Defoamer.
`
`Polyoxyethylene (8)
`Stearate (HLB = 11.1)
`
`Polyoxyethylene (20)
`Sorbitan Monostearate
`(HLB = 14.9)
`
`Polyoxyethylene (20)
`Sorbitan Monooleate
`(HLB = 15.0)
`
`Wetting agent.
`Increases hydrophilic
`properties of clay suspending
`agents.
`
`Wetting agent.
`
`Wetting agent.
`Solubilizer for flavors.
`Viscosity control.
`
`Sodium Lauryl Sulfate
`(HLB = 40)
`
`Wetting agent.
`
`Sorbitan Monolaurate
`(HLB = 8.6)
`
`Wetting agent.
`
`% W/V Range Used
`
`0.1-0.3
`
`Problem
`Incompatibility with drug, suspending
`agent, or protective colloid.
`
`10-40
`
`—
`
`10-60
`
`0.1-1.0
`
`0.1-0.5
`
`0.05-0.1
`
`0.1-0.5
`
`Cap locking.
`Incompatibility with suspending agent.
`Drug incompatibility possible but rare.
`
`—
`
`—
`
`—
`
`Can solubilize small percentage of drug.
`Taste is soapy and bitter.
`
`0.001-0.05
`
`Powerful solubilizer.
`Can solubilize some drugs.
`
`0.001-0-05
`
`—
`
`10
`
`000010
`
`

`

`Avicel® RC and CL Microcrystalline Cellulose, NF
`
`Introduction
`
`Colloidal Avicel is not a water-soluble cellulose
`derivative, but a water-dispersible organic
`hydrocolloid. It is prepared by chemical
`depolymerization of highly purified wood pulp.
`The original crystalline areas of the fiber are
`combined with sodium carboxymethylcellulose
`(NaCMC) to produce the colloidal Avicel product.
`NaCMC serves as a protective colloid and also
`aids in dispersion of the product. Soluble
`hydrocolloids (e.g., NaCMC) are produced by
`chemical substitution of functional groups in
`cellulose. Other types of cellulose products
`(e.g., flocs) are made by mechanical grinding
`of pulp fibers to a finer particle size. Thus, with
`the microcrystalline celluloses, we have a
`different class of products with different
`properties and different functions.
`
`RC and CL types of Avicel microcrystalline
`cellulose (MCC) are water-dispersible products
`for use in pharmaceutical and cosmetic prepara-
`tions. They contain sodium carboxymethylcellu-
`lose (NaCMC) to aid dispersion and to serve
`as a protective colloid.
`
`Structure and Properties
`
`There are four types of Avicel RC/CL: RC-501,
`RC-581, RC-591, and CL-611. All types are
`white, odorless, and tasteless hygroscopic
`powders. They are insoluble in organic solvents
`and dilute acids, and partially soluble in both
`dilute alkali and water (CMC fraction). Due to
`the small size of the microcrystals (about 60%
`of the crystallites in the dispersion are < 0.2µm),
`there are a large number of microcrystals packed
`in each powder particle. The large number of
`small microcrystals foster product elegance by
`slowing the rate of sedimentation, increasing
`the stability of a dispersion, and eliminating hard
`packing of settled particles. The highly compact
`nature of the powder particle is evident in the
`scanning electron micrograph as shown in
`Figure 2.
`
`To achieve maximum dispersion, RC-501 and
`RC-581 require high shear mixing while RC-591
`and CL-611 require low to moderate shear
`mixing. With RC-501, RC-581, RC-591, and
`CL-611, approximately 60% of the particles in
`the dispersion are less than 0.2µm when proper-
`ly dispersed. Concentrations of less than 1%
`solids produce fluid dispersions, while concen-
`trations of more than 1.2% solids produce
`thixotropic gels. CL-611 needs a concentration
`slightly higher than 1.2% for thixotropy.
`
`When stirred in water, Colloidal Avicel powder
`disperses to form either a colloidal sol or a white
`opaque gel, depending on the Avicel concentra-
`tion. When properly dispersed in water, the
`individual RC-591 powder particles disintegrate
`and form a dispersion of cellulose microcrystal
`aggregates. These aggregates are elongated
`solid particles that range in size from a few
`microns to a few tenths of a micron. At concen-
`trations of less than 1% solids, Avicel RC-591
`forms colloidal pseudoplastic dispersions; but
`at concentrations greater than 1%, thixotropic
`gels are formed.
`
`Even though Avicel RC-591 and RC-581 are
`equivalent in colloid content and gel strength
`when fully peptized, high shear equipment such
`as colloid mills and homogenizers are required
`for dispersion of Avicel RC-581. In this case,
`the point of complete or maximum RC-581
`peptization must be predetermined, and an “in
`process” viscosity control has to be established
`in order to equate time versus number of passes
`through a colloid mill (or homogenizer) versus
`viscosity. A consistent maximum hydration
`value must be obtained.
`
`On a practical basis, a colloid mill or Manton
`Gaulin-1000 psi homogenizer is representative
`of the most efficient equipment for processing
`Avicel RC-581 MCC dispersions. The most effi-
`cient mixer, a Waring blender, is not considered
`standard production equipment in the pharma-
`
`11
`
`000011
`
`

`

`ceutical industry. Care should be exercised not
`to lose sight of this fact when formulating
`(on a laboratory scale) a product geared for
`production. Avicel® RC-591 or Avicel CL-611,
`when used alone or with other hydrocolloids,
`is the microcrystalline cellulose of choice for
`
`the preparation of suspensions.
`
`Avicel RC-501, RC-581, RC-591, and CL-611
`are listed as Microcrystalline Cellulose and
`Carboxymethylcellulose Sodium in the U.S.
`Pharmacopoeia/National Formulary.
`
`Figure 2: Fully peptized (activated) Avicel colloidal microcrystalline cellulose
`
`1 ␮M
`
`Chemical and Physical Specifications
`
`Microcrystalline Cellulose and Carboxymethylcellulose Sodium, NF, BP
`
`Avicel RC-501
`
`Avicel RC-581
`
`Avicel RC-591
`
`Avicel CL-611
`
`*NMT 6.0
`NMT 0.001
`7.1-11.9
`+60 mesh NMT 0.1
`+200 mesh NMT 40
`6.0-8.0
`72-168
`(2.1 % solids)
`
`*NMT 6.0
`NMT 0.001
`8.3-13.8
`+60 mesh NMT 0.1
`+200 mesh NMT 35
`6.0-8.0
`72-168
`(1.2% solids)
`
`*NMT 6.0
`NMT 0.001
`8.3-13.8
`+60 mesh NMT 0.1
`+325 mesh NMT 45
`6.0-8.0
`39-91
`(1.2% solids)
`
`*NMT 6.0
`NMT 0.001
`11.3-18.8
`+60 mesh NMT O.1
`+325 mesh NMT 50
`6.0-8.0
`50-118
`(2.6% solids)
`
`NMT 5.0
`
`NMT 5.0
`
`NMT 5.0
`
`NMT 5.0
`
`Product
`Specifications
`Loss on drying, %
`Heavy metals, %
`NaCMC, %
`Sieve fraction, wt. %
`
`pH
`Viscosity, cps
`
`Residue on
`ignition, %
`
`*Not More Than
`
`12
`
`000012
`
`

`

`Microbiological Specifications
`
`Total aerobic microbial count/g........................................................................................NMT 100
`Total yeast and mold count/g.............................................................................................NMT 20
`Escherichia coli.............................................................................. None present in a 10g sample
`Staphylococcus aureus..................................................

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket